Trending stocks

Krbl CAPEX dropped on 25.7% while Revenue increased on 6.8%

26-05-2016 • About Krbl ($KRBL) • By InTwits

Krbl reported FY2016 financial results today. Overall the company's long term financial model is characterised by the following facts:
  • Krbl is a growth stock: FY2016 revenue growth was 6.8%, 5 year revenue CAGR was 16.9% at FY2016 ROIC 17.6%
  • EBITDA Margin is relatively stable: 15.8% in FY2016 vs. 15.4% in FY2015 vs. 14.1% in FY2012
  • Krbl has medium CAPEX intensity: 5 year average CAPEX/Revenue was 5.3%. At the same time it's a lot of higher than industry average of 2.9%.
  • CAPEX is quite volatile: ₹1,723m in FY2016, ₹2,321m in FY2015, ₹1,772m in FY2014, ₹829m in FY2013, ₹666m in FY2012
  • The company has highly profitable business model: ROIC is 17.6%
  • It operates with high leverage: Net Debt/EBITDA is 2.1x while industry average is 0.4x
Below you can find a comprehensive analysis of the key data driving the company's performance and the stock price.

Revenue and profitability


Krbl's Revenue increased on 6.8%. During FY2012-FY2016 Revenue growth topped in FY2014 at 39.9% and was decelerating since that time. EBITDA Margin showed almost no change in FY2016. EBITDA Margin followed a growing trend at 0.46 pp per annum in FY2012-FY2016.

Net Income margin showed almost no change in FY2016. Net Income margin stuck to a growing trend at 1.5 pp per annum in the last 5 years.

Investments (CAPEX, working capital and M&A)


Krbl's CAPEX/Revenue was 5.1% in FY2016. Krbl's CAPEX/Revenue increased slightly on 1.1 pp from 4.0% in FY2013 to 5.1% in FY2016. Average CAPEX/Revenue for the last three years was 6.2%.

Return on investment


The company operates at high and attractive ROE (22.9%) while ROIC is a bit lower (17.6%). ROIC increased slightly on 0.60 pp from 17.0% to 17.6% in FY2016. ROE decreased on 4.3 pp from 27.2% to 22.9% in FY2016. During the last 5 years ROE topped in FY2014 at 27.2% and was declining since that time.

Leverage (Debt)


Company's Net Debt / EBITDA is 2.1x and Debt / EBITDA is 2.2x. Net Debt / EBITDA dropped on 0.6x from 2.7x to 2.1x in FY2016. Debt dropped on 14.1% while cash jumped on 15.2%. Net Debt/EBITDA followed a declining trend at -0.4x per annum in FY2012-FY2016.

Krbl has short term refinancing risk: cash is only 2.9% of short term debt.

Valuation and dividends


The company's trades at EV/EBITDA 14.1x and P/E 18.9x while industy averages are 17.8x and 21.9x. Krbl's EV/(EBITDA-CAPEX) is 20.8x with the industry average at 22.8x.

Financial and operational results


Krbl ($KRBL) key annual financial indicators

mln. INR201220132014201520162016/2015
P&L
Revenue16,31020,80429,10531,59733,7386.8%
SG&A783
EBITDA2,3032,9604,3934,8815,3309.2%
Net Income7301,2992,5513,2173,3714.8%
Balance Sheet
Cash3110765824027615.2%
Short Term Debt8,3167,92911,71211,1479,598-13.9%
Long Term Debt1,0647742,0832,3632,006-15.1%
Cash flow
Capex6668291,7722,3211,723-25.7%
Ratios
Revenue growth5.6%27.6%39.9%8.6%6.8%
EBITDA growth1.5%28.5%48.4%11.1%9.2%

EBITDA Margin14.1%14.2%15.1%15.4%15.8%0.4%
SG&A, % of revenue2.3%
Net Income Margin4.5%6.2%8.8%10.2%10.0%-0.2%
CAPEX, % of revenue4.1%4.0%6.1%7.3%5.1%-2.2%

ROIC11.7%14.5%18.3%17.0%17.6%0.6%
ROE10.7%16.8%27.2%27.2%22.9%-4.3%
Net Debt/EBITDA4.1x2.9x3.0x2.7x2.1x-0.6x

Peers in Packaged Foods


Below you can find Krbl benchmarking vs. other companies in Packaged Foods industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.

Top companies by Revenue growth, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Simran Farms ($SIMRAN)38.4%23.8%27.5%23.4%-
Heritage Foods ($HERITGFOOD)-15.0%7.5%20.4%14.8%
Rcl Foods ($RCLFOODS)-56.8%-34.2%18.2%17.8%-
Kwality ($KWALITY)-62.6%27.5%17.3%9.1%
Umang Dairies ($UMANGDAIR)-15.7%24.5%16.1%-24.8%
 
Median (18 companies)18.0%15.0%15.7%7.0%3.3%
Krbl ($KRBL)-27.6%39.9%8.6%6.8%


Top companies by EBITDA margin, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Zydus Wellness ($ZYDUSWELL)23.1%25.4%22.6%23.8%21.3%
Nestle India ($NESTLEIND)22.0%21.7%20.9%19.7%-
Glaxosmithkline Consumer Healthcare ($GSKCONS)18.6%17.8%22.5%17.2%19.4%
Sampre Nutritions ($SAMPRE)---16.8%-
Adf Foods ($ADFFOODS)13.5%11.2%8.6%14.5%-
 
Median (20 companies)7.2%7.1%8.6%6.6%10.2%
Krbl ($KRBL)14.1%14.2%15.1%15.4%15.8%


Top companies by CAPEX/Revenue, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Venky'S (India) ($VENKYS)8.9%6.6%10.4%7.7%-
Umang Dairies ($UMANGDAIR)2.0%4.4%2.7%3.2%-
Glaxosmithkline Consumer Healthcare ($GSKCONS)2.7%-4.3%2.5%1.4%
Heritage Foods ($HERITGFOOD)2.1%1.9%3.7%2.5%2.9%
Vadilal Industries ($VADILALIND)12.2%9.4%5.9%2.2%-
 
Median (10 companies)3.3%3.7%3.2%2.0%2.9%
Krbl ($KRBL)4.1%4.0%6.1%7.3%5.1%


Top companies by ROIC, %

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Kse ($KSE)27.7%14.1%36.9%69.0%-
Britannia Industries ($BRITANNIA)24.6%33.7%54.0%59.4%66.7%
Nestle India ($NESTLEIND)57.7%47.9%49.6%40.2%-
Glaxosmithkline Consumer Healthcare ($GSKCONS)44.6%--36.2%35.7%
Umang Dairies ($UMANGDAIR)93.5%55.6%22.3%28.4%-
 
Median (22 companies)12.3%14.1%22.3%24.5%26.3%
Krbl ($KRBL)11.7%14.5%18.3%17.0%17.6%


Top companies by Net Debt / EBITDA

Top 5 FY2012 FY2013 FY2014 FY2015 FY2016
Kwality ($KWALITY)3.9x3.9x3.6x8.1x3.6x
Vadilal Industries ($VADILALIND)2.6x4.5x3.9x4.0x-
Venky'S (India) ($VENKYS)2.6x2.8x6.7x3.9x-
Bambino Agro Industries ($BAMBINO)3.2x-3.2x2.9x-
Heritage Foods ($HERITGFOOD)2.2x0.9x1.0x1.4x0.5x
 
Median (18 companies)1.7x0.8x1.0x0.0x0.0x
Krbl ($KRBL)4.1x2.9x3.0x2.7x2.1x